MT SJ33

Requests the Legislative Council to conduct an interim study examining Montana's prescription drug supply chain, including pharmacies, pharmacy benefit managers, manufacturers, wholesalers, and health plans

Directs analysis of factors contributing to pharmacy openings and closures, with particular attention to economic pressures, staffing, and geographic considerations affecting rural and underserved areas

Requires the study to use only aggregated, publicly available, or voluntarily provided data—no proprietary or confidential business information may be requested or compelled

Mandates stakeholder engagement across the supply chain, with all feedback supported by citations and source documentation

Study must be completed by September 15, 2026, with final results and recommendations for statutory, regulatory, or rule changes reported to the 70th Legislature